Fachnetzwerk Infektionen

The Study Network Infectious Diseases (SNID) is the first use case within the NUM Study Network of the Network University Medicine (NUM) and is specifically designed to strengthen clinical and clinical-epidemiological research in infectious diseases.

Its aim is to establish a high-performance recruitment platform for three categories of studies:

• Since May 2025: Internal studies such as the SNID basic cohort, which recruits patients from the modules respiratory infections, bloodstream infections, gastrointestinal infections, central nervous system infections, and emerging infectious diseases, as well as the international platform study SNAP and RAPID-REVIVE

• From February 2026: Additional NUM-funded studies, including sWITCH-VO, PENGUIN, FOSFO-SNAP, CanTEN, PRÄVENTIV, and ELAPSE

• Planned: Externally funded academic and commercial studies

A key element is the development of prescreening programmes using automated tools to reliably identify patients at study sites. These programmes support feasibility assessments, increase participation rates, and enable early detection of shifts in disease patterns relevant for pandemic monitoring.

Data and biosamples collected within SNID will be made available to the scientific community upon request, providing a robust basis for further research to improve diagnostics, therapy, and prevention in infectious diseases.

Duration: July 2024 – June 2030

Funding: Funded by the Network University Medicine (NUM) and the German Federal Ministry of Education, Research, Technology and Space (BMFTR)

Duration: July 2024 – June 2030

Project Leads: Prof. Dr. Janne Vehreschild (Scientific Lead) and Dr. Margarete Scherer (Operational Lead)

Website: sn.netzwerk-universitaetsmedizin.de